Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan.
Vaccine: X(2023)
摘要
An effective maternal GBS vaccine is likely to be considered cost-effective in Japan at a price of ¥5,000/dose. Effectiveness against other adverse perinatal outcomes would increase health benefits and cost-effectiveness.
更多查看译文
关键词
Group B streptococcus (GBS), Vaccine, Maternal immunization, Cost-effectiveness analysis, Neonatal sepsis, Neonatal meningitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要